Novel Heteroaromatic Carboxamide Derivatives as Plasma Kallikrein Inhibitors for Treating Diabetic Complications, Ocular Diseases and Edema-Associated Diseases
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.